Transplantation of cellular therapeutics to the spinal
cord is conventionally done with either systemic
administration, or local injection following surgical
exposure of the spinal cord. For intraparenchymal
transplantation, targeting to the spinal cord is based
on a combination pre-operative MRI measurements and
anatomical landmarks. Our group developed an
MR-compatible spinal cord injection system capable of
replacing invasive surgical procedures. Here we present
the proof-of-principle for percutaneous,
intraparenchymal transplantation of stem cells into the
spinal cord of a live Gottingen minipig under MRI
guidance.

This abstract and the presentation materials are available to members only;
a login is required.